Only under stressed conditions (e.g., tumor growth) its deletion or mutation makes the eIF2B complex insensitive to the inhibitory effects of eIF2α phosphorylation (Dever et al, 1993; Hannig et al, 1990; Pavitt et al, 1997). The gene discussed is EIF2B2; the disease is neoplasm.